Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

HK Type 4 license through Ballingal Investment Advisors Ltd. 

I'm a highly experienced sell-side analyst with in excess of 22 years of covering Asia Pacific equities, the past 19 years immersed in event strategies encompassing M&A risk arbitrage, directional long/short, stub trades and restructuring.  

My background also includes accountancy (liquidation/bankruptcy/receivership) earlier in my career and as a chief financial officer of a global commodity company based in the US and Mexico.

Pan-Asia Catalysts/Events

Virtus Health: How BGH's Offer Plays Out From Here

Virtus Health: Offer From BGH Now Ostensibly Unconditional

Shareholder Vote On 6 June For Virtus-Backed Offer From CapVest

Quiddity Advisors

Event-Driven

<ul>
<li>With a little under two weeks until <strong><a href="https://www.smartkarma.com/entities/virtus-health-ltd" target="_blank" data-smartkarma-citation="entities:14776:1" rel="noopener">Virtus Health (VRT AU)</a></strong> shareholders vote on CapVest's Offer, BGH bumps its off-market bid to $8.15/share, matching CapVest's Scheme terms.</li>
<li>BGH added it now holds 22.38% and will vote against CapVest's Offer. Virtus has encouraged CapVest to respond today about whether they will increase terms. </li>
<li>With CapVest's Scheme all-but blocked, BGH's revised $8.15/share Offer is now the highest offer for Virtus.</li>
</ul>


With a little under two weeks until Virtus Health (VRT AU) shareholders vote on CapVest's Offer, BGH bumps its off-market bid to $8.15/share, matching CapVest's Scheme terms.
BGH added it now holds 22.38% and will vote against CapVest's Offer. Virtus has encouraged CapVest to respond today about whether they will increase terms. 
With CapVest's Scheme all-but blocked, BGH's revised $8.15/share Offer is now the highest offer for Virtus.


Virtus: BGH Bumps; CapVest's Scheme Untenable